Acceleron Pharma Inc Asset Turnover Ratio (XLRN), as of third quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Acceleron Pharma inc  (NASDAQ: XLRN)
 

Acceleron Pharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Acceleron Pharma Inc asset turnover ratio, the ability of Acceleron Pharma Inc's assets to generate revenue in the third quarter 2021, increased sequentially to 0.13 in the third quarter (Sep 30 2021), XLRN's balance sheet remain strong.

Within sector 40 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2021 compared to the preceding quarter from 2589 to 3065.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XLRN Asset Turnover Ratio (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Asset Change -17.13 % 78.31 % 84.56 % 88.87 % 79.04 %
Y / Y Revenue Change 51.58 % -29.71 % 469.94 % -34.25 % 436.15 %
Asset Turnover Ratio (TTM) 0.13 0.11 0.14 0.13 0.18
XLRN's Total Ranking # 3065 # 2589 # 2952 # 3058 # 3065
Seq. Asset Change -5.92 % -4.33 % -6.13 % -1.91 % 102.43 %
Seq. Revenue Change 22.4 % 12.85 % -4.28 % 14.65 % -43.25 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 41
Healthcare Sector # 447
Overall Market # 3065

Asset Turnover Ratio Statistics
High Average Low
0.18 0.1 0.03
(Jun 30 2020)   (Mar 31 2019)




XLRN Company Profile • Back to XLRN Efficiency Comparisons • Compare XLRN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2021 Assets at quarter ending Sep 30 2021
Siga Technologies Inc  0.40 $ 56.043  Millions$ 139.462  Millions
Bristol myers Squibb Company  0.40 $ 45,468.000  Millions$ 113,151.500  Millions
Anika Therapeutics Inc   0.40 $ 144.661  Millions$ 360.980  Millions
Innoviva Inc   0.40 $ 374.662  Millions$ 941.062  Millions
Thermogenesis Holdings Inc   0.39 $ 8.823  Millions$ 22.407  Millions
Immunogen inc   0.39 $ 127.662  Millions$ 324.821  Millions
Biocryst Pharmaceuticals Inc   0.39 $ 114.028  Millions$ 290.548  Millions
Pacira Biosciences inc   0.39 $ 513.313  Millions$ 1,310.974  Millions
Teleflex Incorporated  0.39 $ 2,758.828  Millions$ 7,071.733  Millions
Emmaus Life Sciences Inc   0.39 $ 23.842  Millions$ 61.274  Millions
Cartesian Therapeutics Inc   0.39 $ 67.091  Millions$ 172.466  Millions
Surgery Partners Inc   0.39 $ 2,163.200  Millions$ 5,576.100  Millions
T2 Biosystems Inc   0.39 $ 28.866  Millions$ 74.516  Millions
Horizon Therapeutics Public Limited Company  0.38 $ 2,957.260  Millions$ 7,683.833  Millions
Perrigo Company Plc  0.38 $ 4,323.300  Millions$ 11,239.850  Millions
Pfizer Inc  0.38 $ 63,600.000  Millions$ 165,538.750  Millions
Crispr Therapeutics Ag  0.38 $ 902.434  Millions$ 2,376.780  Millions
Atricure Inc   0.38 $ 258.836  Millions$ 682.121  Millions
Sonida Senior Living Inc   0.38 $ 257.319  Millions$ 685.697  Millions
Becton Dickinson And Company  0.37 $ 20,248.000  Millions$ 54,467.000  Millions
Abbvie Inc   0.37 $ 55,169.000  Millions$ 149,474.000  Millions
Boston Scientific Corporation  0.37 $ 11,469.000  Millions$ 31,180.500  Millions
Supernus Pharmaceuticals inc   0.37 $ 564.282  Millions$ 1,534.911  Millions
Alector Inc   0.36 $ 197.944  Millions$ 544.988  Millions
Mannkind Corporation  0.35 $ 81.370  Millions$ 229.747  Millions
Soc Telemed Inc   0.35 $ 80.967  Millions$ 229.771  Millions
Tela Bio Inc   0.35 $ 26.756  Millions$ 76.846  Millions
Assertio Holdings inc   0.35 $ 107.860  Millions$ 310.005  Millions
Kyntra Bio Inc   0.35 $ 283.764  Millions$ 818.318  Millions
United Therapeutics Corporation  0.35 $ 1,655.200  Millions$ 4,787.450  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.